MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: other"

  • 2016 International Congress

    Botulinum toxin treatment of freezing of gait in Parkinson’s disease patients as reflected in functional magnetic resonance imaging of leg movement

    M. Vaštík, P. Hok, P. Hluštík, P. Kanovský, Z. Tüdös (Olomouc, Czech Republic)

    Objective: To reflect botulinum toxin treatment of freezing of gait in Parkinson´s disease patients in functional magnetic resonance imaging of leg movement. Background: Freezing of…
  • 2016 International Congress

    Efficacy and safety of abobotulinumtoxinA in craniocervical dystonia and hemifacial spasm

    A. Jesic, D. Stefanovic, N. Delibasic, J. Radanov, M. Cvijanovic (Victoria, Seychelles)

    Objective: The aim of this paper was to analyze efficacy and safety of abobotulinumtoxinA (A/Abo), and compare them between the groups of patients with CD…
  • 2016 International Congress

    Multicentre retrospective chart review of patients treated with incobotulinumtoxinA to evaluate sustained efficacy and tolerability in converted and de-novo conditions

    M.S. Jog, R.M. Jog, A. Tewari, D. Hobson, D. Stewart, D. King (London, ON, Canada)

    Objective: This study aimed to determine whether IncobotulinumtoxinA (IBTX) provides sustained efficacy as a treatment modality patients in both de-novo patients and patients converted from…
  • 2016 International Congress

    Parietal hand pseudodystonia: Significant functional gains with ultrasound-guided botulinum toxin treatments

    P. Pita Lobo, C. Costa (Amadora, Portugal)

    Objective: Case report. Background: Symptomatic focal dystonia is most commonly secondary to lesions involving the basal ganglia. Previous reports have documented the occurrence of focal…
  • 2016 International Congress

    Pseudodystonic upper limb secondary to thalamic lesions: Usefulness of ultrasound-guided botulinum toxin treatment

    C. Costa, P. Pita Lobo (Amadora, Portugal)

    Objective: Case reports. Background: Although botulinum toxin is routinely used as first-line treatment for focal dystonias, little is known about its usefulness in the treatment…
  • 2016 International Congress

    Therapeutic effect of onabotulinumtoxinA (BoNT/A) in hemifacial spasm and trigeminal neuralgia post Ramsay Hunt Syndrome type II

    R. López-Castellanos, R. López-Contreras (San Salvador, El Salvador)

    Objective: To evaluate the therapeutic and preventive effect of OnabotulinumtoxinA (BoNT/A) in the treatment of hemifacial spasm, bruxism, and trigeminal neuralgia post Ramsay Hunt Syndrome.…
  • 2016 International Congress

    A case of hemifacial spasm with a right-sided pontine meningioma that resolved with PICA loop vascular decompression surgery

    E.M. Feinstein, S.J. Frucht (New York, NY, USA)

    Objective: To improve our understanding of the pathophysiology and etiology of hemifacial spasm (HFS). Background: HFS is involuntary unilateral contractions of the muscles innervated by…
  • 2016 International Congress

    Differences in physicians’ understanding of biologic and biosimilar medicines in the USA and Europe

    A.L. Molinari, H.L. Gewanter, M. Reilly, D. Charles (Washington, DC, USA)

    Objective: To evaluate differences in physicians' understanding of biologic and biosimilar medicines in the USA and Europe. Background: Biologic medicines, such as botulinum toxins and…
  • 2016 International Congress

    A double blind investigation of efficacy and safety of incobotulinumtoxinA in Parkinson’s disease tremor- A customized injection approach

    S.O. Mittal, R. Rostami, D.G. Machado, D. Richardson, B. Jabbari (Cleveland, OH, USA)

    Objective: To evaluate the safety and efficacy of incobotulinumtoxinA (IncoA) injection in the tremor of Parkinson's disease (PD). Background: Unlike other cardinal motor features of…
  • 2016 International Congress

    Patient satisfaction with flexible botulinum toxin injection intervals – Preliminary results of a telephone survey

    C. Linder, S. Macher, E. Auff, T. Sycha (Vienna, Austria)

    Objective: To evaluate satisfaction with flexible injection intervals in patients receiving Botulinum toxin therapy at our outpatient clinic. Background: Botulinum toxin therapy (BoNT) for muscular…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley